Marizyme, Inc. Jupiter, Florida 3345810% Secured Convertible Promissory Notes • October 4th, 2023 • Marizyme, Inc. • Pharmaceutical preparations
This letter agreement (this “Letter Agreement”) confirms our recent discussions about an amendment to each Note in order to confirm and clarify the intent of the parties with respect to the convertibility of the Mandatory Default Amount (as defined in each Note) and certain related matters. Univest Securities, LLC, as Unitholder Representative for the Investors pursuant to Section 11.16 of each Unit Purchase Agreement, confirms that it has the authority to agree to the following amendment to each Note on behalf of each Investor pursuant to Section 11.16.
Marizyme, Inc. Jupiter, Florida 3345810% Secured Convertible Promissory Notes • December 28th, 2023 • Marizyme, Inc. • Surgical & medical instruments & apparatus
Reference is made to each (a) Unit Purchase Agreement dated as of December 21, 2021(each, as amended, superseded, replaced, or otherwise modified from time to time, the “Unit Purchase Agreement”), between the Company and the investor identified therein (individually, “Investor” and collectively, “Investors”); and (b) 10% Secured Convertible Promissory Note issued to such Investor in connection with such Unit Purchase Agreement, if not repaid or converted in full or otherwise cancelled or fully discharged in accordance with its terms or by law prior to the date hereof (as amended, superseded, replaced, or otherwise modified from time to time, “Note”) issued to such Investor in connection with such Unit Purchase Agreement. Capitalized terms used but not defined herein shall have the meanings given to them in the Unit Purchase Agreement, or if not defined therein, in the Note, or if not defined therein, in any of the applicable Transaction Documents (as defined in the Unit Purchase Agreem
